YULIYA SCHOENLING: Open Payments
NPI 1932351624 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 116 payments from 17 companies in 2025. Trend: 2023 $1,366 · 2024 $2,037 · 2025 $2,046
Food & beverage: $1,966Education: $80
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $236 |
| LEO Pharma Inc. | 12 | $231 |
| GENZYME CORPORATION | 6 | $209 |
| ABBVIE INC. | 23 | $208 |
| Arcutis Biotherapeutics, Inc. | 11 | $193 |
| Novartis Pharmaceuticals Corporation | 10 | $175 |
| Regeneron Healthcare Solutions, Inc. | 5 | $163 |
| Janssen Biotech, Inc. | 4 | $135 |
| Amgen Inc. | 10 | $135 |
| UCB, Inc. | 5 | $102 |
Products named: DUPIXENT, NEMLUVIO, ADBRY, Zoryve, SKYRIZI, TREMFYA, OTEZLA, COSENTYX.
Industry payments across AZ — which companies pay providers there.
